Pharmaceutical Technology Europe-10-01-2012

Pharmaceutical Technology Europe

Seeking Solutions in Solid-State Chemistry

October 01, 2012

Ingredients

24

10

The physical form of an API is an important consideration in formulation development. Particle-engineering technologies, such as crystal design for controlling crystallisation and producing cocrystals, particle-size reduction and amorphous solid dispersions, help to optimise delivery of a drug.

EMA Focuses on Greater International Collaboration

October 01, 2012

Industry Insider

24

10

EMA has been increasing its interactions with other regulatory agencies across the globe. The agency's most talked about collaboration is with FDA, but EMA has also been intently focused on bolstering its relationship with its counterparts in Japan, India and Russia.

Pharmaceutical Technology Europe, October 2012 Issue (PDF)

October 01, 2012

Issue PDF

24

10

Click the title above to open the Pharmaceutical Technology Europe October 2012 issue in an interactive PDF format.